1. Randomized trial experience of the IFM;Attal,2001
2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996
3. Badros A, Barlogie B, Siegel E, et al: High dose therapy and autologous stem cell support in multiple myeloma patients over age 70: A single center experience. Br J Hematol (in press)
4. Melphalan-based high dose therapy (HDT) with peripheral blood stem cell (PBSC) support is safe and effective in multiple myeloma (MM) with renal failure;Badros;Blood,2000
5. Hypothyroidism in patients with multiple myeloma (MM) receiving thalidomide;Badros;Blood,2000